In mice bearing the H22 tumor, chiisanoside (120 mg/kg and 240 mg/kg) effectively suppresses tumor growth while upregulating the expression of cytokines such as IL-2, TNF-α, and IFN-γ. Here, IFNG is linked to neoplasm.